Movatterモバイル変換

Lenvervimab

From Wikipedia, the free encyclopedia

Monoclonal antibody

Pharmaceutical compound

Lenvervimab
Monoclonal antibody
Type	?
Source	Humanized
Target	hepatitis B virus surface antigen
Clinical data
Other names	GC1102
ATC code	none
Identifiers
CAS Number	2055006-79-4
DrugBank	DB17814
UNII	FX9X4L2A2L

Lenvervimab (INN;^[1] development codeGC1102) is a monoclonal antibody that is being investigated forhepatitis B.^[2]

This drug is being developed by GC Pharma. As of 2018^[update], lenvervimab is undergoingPhase II/III trials.

Human	Efungumab^†

Human	Ansuvimab Atoltivimab (+maftivimab/odesivimab) Avdoralimab^§ Bamlanivimab^† (+etesevimab)^† Bebtelovimab^§ Casirivimab^† (+imdevimab) Cilgavimab^† (+tixagevimab)^† Clesrovimab Diridavumab^§ Etesevimab^† Exbivirumab^§ Foravirumab^§ Imdevimab^† (+casirivimab) Libivirumab^§ Maftivimab Nirsevimab^† Odesivimab Pemivibart Rafivirumab^§ Regavirumab^§ Regdanvimab Sevirumab^† Sipavibart Sotrovimab Suptavumab Tixagevimab^† (+cilgavimab)^† Tuvirumab^§
Chimeric	Cosfroviximab Larcaviximab Porgaviximab Vilobelimab^†
Humanized	Felvizumab^§ Lenvervimab^† Motavizumab^† Palivizumab Suvizumab^§

Human	Nebacumab Panobacumab^§ Raxibacumab
Mouse	Edobacomab^§
Chimeric	Pagibaximab^†
Humanized	Tefibazumab^†

Human	Actoxumab^§ Bezlotoxumab Suvratoxumab
Chimeric	Obiltoxaximab
Humanized	Urtoxazumab^§

Thismonoclonal antibody–related article is astub. You can help Wikipedia byadding missing information.

Hidden categories: